欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/4755/001
药品名称Laryngomedin Octenidin Antisept
活性成分
    • OCTENIDINE DIHYDROCHLORIDE 2.6 mg
剂型Lozenge
上市许可持有人Cassella-med GmbH & Co.KG Gereonsmühlengasse 1 D-50670 Köln Germany
参考成员国 - 产品名称Germany (DE)
2197417
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Austria (AT)
      Octenidin Cassella-med antisept 2,6 mg Lutschtabletten
    • Poland (PL)
      Octeangin
    • Czechia (CZ)
      Octenidine Klosterfrau
    • Bulgaria (BG)
      Octeangin
    • Hungary (HU)
      OCTEANGIN 2,6 mg szopogató tabletta
    • Slovakia (SK)
    • Romania (RO)
      Octeangin 2,6 mg pastile
许可日期2018/05/17
最近更新日期2024/03/22
药物ATC编码
    • R02AA20 various
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase